Lobaplatin-Induced Apoptosis Requires p53-Mediated p38MAPK Activation Through ROS Generation in Non-Small-Cell Lung Cancer

Platinum-based chemotherapy is recommended as the first-line treatment regimen for patients with advanced non-small-cell lung cancer (NSCLC). Lobaplatin (LBP), a third-generation platinum anti-neoplastic agent, has shown an improved efficacy. This study is aimed to investigate the mechanisms of LBP-...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hongming, Chen, Runzhe, Wang, Xiyong, Zhang, Haijun, Zhu, Xiaoli, Chen, Jibei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689983/
https://www.ncbi.nlm.nih.gov/pubmed/31428569
http://dx.doi.org/10.3389/fonc.2019.00538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689983/
https://www.ncbi.nlm.nih.gov/pubmed/31428569
http://dx.doi.org/10.3389/fonc.2019.00538

Ejemplares similares